BTG raises revenue forecasts
BTG, the specialist healthcare company, said it had outperformed in the first half and was boosting its revenue expectations for the full year.
BTG, the specialist healthcare company, said it had outperformed in the first half and was boosting its revenue expectations for the full year.
The firm said is raising its revenue estimate for the year ending March 31st 2013 from £190m-£200m to £205m-£215m after a strong first half performance and a positive outlook for the second.
Trading during the six months to the end of September was ahead of expectations, driven principally by high demand for its snake anti-venom CroFab.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
It also saw a strong start from post-chemotherapy drug Voraxaze following its US nationwide launch at the end of April 2012
Among other products, it also noted the continued growth of royalties from Johnson & Johnson's prostate cancer drug Zytig.
First half revenue also included £5.4m of additional deferred income relating to a previous licence agreement that had been fully following AstraZeneca's decision axe development of CytoFab, nn experimental treatment for severe sepsis that failed in trials.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
Review: Eden Roc Cap Cana – fun, sun and golf in the Caribbean
Travel Eden Roc Cap Cana in the Dominican Republic offers everything from relaxing by the pool to a world-class golf course
-
Reeves delays cash ISA reform, but savers are not out of the woods yet
The chancellor has reportedly delayed plans to cut the cash ISA limit, which were set to be announced at Mansion House on 15 July, and will take more time to consult with the industry